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التامور بني املرضى الذين يوجد لديهم اشتباه مرض الشريان التاجي
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abstract: Objectives: This study aimed to assess the effect of body mass index (BMI) on the relationship between 
pericardial fat volume (PFV), aortic root calcification (ARC) and coronary artery calcification (CAC) among patients 
with suspected coronary artery disease (CAD). Methods: This cross-sectional study took place between January 
and December 2014 at the Kufa University Teaching Hospital, Najaf, Iraq. A total of 130 consecutive patients with 
an intermediate pretest probability of ischaemic heart disease who underwent 64-slice multidetector computed 
tomography (CT) angiography during the study period were recruited. Of these, 111 were included in the study 
and divided into groups according to BMI. Imaging markers were measured on CT angiography. Results: A total of 
28 patients were obese, while 42 and 41 were overweight and normal weight, respectively. The median PFV, CAC 
and ARC was 109 cm3 (interquartile range [IQR]: 52–176 cm3), 0 Agatston score (IQR: 0–52 Agatston score) and 
0 Agatston score (IQR: 0–15 Agatston score), respectively, in the normal weight group in comparison to 79 cm3 
(IQR: 43–138 cm3), 0 Agatston score (IQR: 0–54 Agatston score) and 0 Agatston score (IQR: 0–0 Agatston score), 
respectively, in the obese group. Significant correlations were observed between PFV and CAC (r2 = 0.22; P = 0.002) 
and ARC and CAC (r2 = 0.37; P <0.001) in the normal weight group. However, no significant correlations were 
observed for obese and overweight patients. Conclusion: These findings indicate that BMI may not be an accurate 
tool for measuring adiposity or assessing subclinical coronary atherosclerosis in patients with suspected CAD.
Keywords: Body Mass Index; Obesity; Pericardium; Coronary Vessels; Vascular Calcification; Atherosclerosis; 
Coronary Angiography.
امللخ�ص: اأهداف: هدفت هذه الدرا�صة اإىل تقييم تاأثري دليل كتلة اجل�صم )BMI( على العالقة بني حجم الدهون يف التامور )PFV( مع تكل�ض 
 .)CAD( بني املر�صى الذين يعانون من ا�صتباه مر�ض ال�رضيان التاجي )CAC( وتكل�ض ال�رضيان التاجي )ARC( جذر ال�رضيان االأبهر
منهجية: اأجريت هذه الدرا�صة امل�صحية يف الفرتة ما بني يناير ودي�صمرب 2014م يف امل�صت�صفى التعليمي جلامعة الكوفة يف النجف، العراق، 
خالل فرتة الدرا�صة مت ح�رض ما جمموعه 130 مري�صًا على التوايل من بني امل�صتبه باإ�صابتهم مبر�ض نق�ض تروية القلب وخ�صعوا للفح�ض 
 130 جمموع  من  مري�ض،  لكل  اإ�صعاعي  مقطع   64 وت�صوير   )CT( املحو�صب  املقطعي  الك�صف  متعدد  الدموية  االأوعية  ت�صوير  جهاز  يف 
مري�صا،ً مت اإدراج 111 منهم يف الدرا�صة وتق�صيمهم اإىل جمموعات وفقًا لدليل كتلة اجل�صم. نتائج: كان هناك 28 مري�صًا يعانون من ال�صمنة 
و 42 من فرط يف الوزن، بينما كان 41 مري�صًا الباقني ذو وزن طبيعي، بلغ متو�صط حجم الدهون يف التامور وتكل�ض ال�رضيان التاجي و 
تكل�ض جذر ال�رضيان االأبهر 109 �صم مكعب )مدى املعدل الرباعي من 176–52 �صم مكعب(، نتيجة اأجات�صون 0 )مدى رباعي 52-0(ونتيجة 
اأجات�صون 0 )مدى رباعي 15–0( على التوايل يف حاالت الوزن الطبيعي، مقارنًة مبعدل متو�صط 79 �صم مكعب )مدى رباعي 138-43 �صم 
0–0 من النتيجة( على التوايل يف جمموعة املر�صى  )مدى رباعي   0 اأجات�صون  ونتيجة   )0-54 )مدى رباعي   0 اأجات�صون  مكعب(، نتيجة 
)r2 = 0.22; P = 0.002( ذوي ال�صمنة، لوحظ وجود ارتباط ذو داللة اإح�صائية بني حجم الدهون يف غ�صاء التامور وتكل�ض ال�رضيان التاجي
و بني تكل�ض ال�رضيان التاجي وتكل�ض جذر ال�رضيان االأبهر )r2 = 0.37; P >0.001( يف جمموعة املر�صى ذوي الوزن الطبيعي، يف حني مل 
يالحظ اأي ارتباط ملمو�ض بني هذه املوؤ�رضات يف الذين يعانون من ال�صمنة وفرط الوزن. خامتة: ت�صري هذه النتائج اإىل اأن دليل كتلة اجل�صم 
قد ال يكون اأداة دقيقة لقيا�ض ال�صمنة اأو تقييم وجود ت�صلب ال�رضايني التاجية حتت ال�رضيري يف املر�صى الذين يعانون من ا�صتباه مر�ض 
ال�رضيان التاجي.
كلمات مفتاحية: دليل كتلة اجل�صم؛ ال�صمنة؛ غ�صاء التامور؛ االوعية التاجية؛ تكل�ض وعائي؛ ت�صلب ع�صيدي؛ ت�صوير االوعية التاجية.
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Advances in Knowledge
- This study examines the role of emerging imaging markers—coronary artery calcification, aortic root calcification and pericardial fat 
volume (PFV)—in coronary atherosclerosis among patients with different body mass indexes (BMIs).
- The results of this study suggest that BMI does not accurately predict the role and distribution of adipose tissue in patients with 
cardiovascular disease.
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Over the last few decades, the global prevalence of obesity has increased drama-tically; this is concerning due to the crucial 
role that obesity plays in metabolic disorders and in 
increasing the risk of cardiovascular disease.1 Several 
non-invasive measurement-based techniques have 
been used to define obesity, including body mass 
index (BMI), waist circumference, waist-to-hip ratio 
and abdominal wall thickness. However, there is as 
yet no optimal method for accurately assessing the 
burden and distribution of adipose tissue believed to 
be involved in coronary and vascular atherosclerosis.2
As a marker of subclinical coronary atherosclerosis, 
coronary artery calcification (CAC) has an incremental 
prognostic role which differs to traditional cardiac risk 
factors and is associated with a higher cardiovascular 
burden and improved coronary risk stratification.3 
Research has shown that CAC is a more effective 
predictor of cardiovascular events and assessment 
of atherosclerosis burden.4 However, little is known 
regarding the relation of aortic root calcification (ARC) 
to coronary atherosclerosis and obesity. Pericardial fat 
is a local fat deposit that covers 80% of the surface of 
the heart, with a close anatomical proximity to the 
epicardial coronary arteries; pericardial fat volume 
(PFV) is an emerging imaging marker that has been 
reported to be involved in coronary atherosclerosis.5–8 
The main aim of this study was to assess the impact 
of BMI on emerging radiological markers of coronary 
atherosclerosis (CAC, ARC and PFV) in patients with 
suspected coronary artery disease (CAD). 
Methods
This cross-sectional study was carried out between 
January and December 2014 at the Cardiology Center 
of the Kufa University Teaching Hospital, Najaf, Iraq. 
A total of 130 consecutive Iraqi patients with suspected 
CAD based on age, gender and the presence of cardiac 
symptoms who had undergone 64-slice multi-detector 
computed tomography (MDCT) angiography for 
assessment of CAD during the study period were 
recruited. The exclusion criteria for a MDCT exam-
ination included haemodynamic instability, a history 
of cardiac surgery, iodine-based contrast allergies, 
renal failure (creatinine levels of ≥1.5 mg/dL), atrial 
fibrillation or other unstable heart rhythms, an 
inability to perform breath-holding, the presence of 
intracardiac devices (e.g. pacemakers), pregnancy or 
contraindications for the use of β-blockers.6 Of those 
recruited, 19 patients were subsequently disqualified 
due to poor imaging technique or motion artifacts 
(n = 8), aortic root anomalies or dissections (n = 2), 
difficulties in accurate PFV calculation or segmentation 
of fat (n = 6) or missing data (n = 3). A total of 111 
patients were hence included in the study and 
divided into obese (BMI of ≥30 kg/m2), overweight 
(BMI of 25–29.9 kg/m2) or normal weight (BMI of 
<25 kg/m2) groups.
Non-contrast multidetector computed tomo-
graphy (CT) was performed on all patients with 
suspected CAD using a sequence scan with a slice 
thickness of 3 mm. Total heart calcium levels were 
measured according to the Agatston method.6 
Thereafter, 64-slice CT coronary angiography was 
performed (Aquilion™ 64, Version 4.51 ER 010, 
Toshiba Medical Systems Corp., Otawara, Japan) 
according to previously defined methods.9,10 The scan 
was obtained from the aortic arch to the level of the 
diaphragm during a single breath-hold. Retrospective 
electrocardiograph (ECG)-gating and ECG-dependent 
tube current modulation was performed using 
defined parameters.9 Following this, CT images were 
reconstructed using a smooth kernel (B25f ) with a 
slice thickness of 0.5 mm (increment of 0.3 mm) and 
data sets were transferred to a VitreaWorkstation™ 
(Vital Images Inc., Minnetonka, Minnesota, USA) for 
image analysis.6
Figure 1: Multi-detector computed tomography showing 
the calculation of aortic root calcification.
LM = left main artery; RCA = right coronary artery; LAD = left 
anterior descending artery; CX = left circumflex coronary artery; 
PDA = posterior descending artery.
Application to Patient Care
- The utilisation of BMI as a measurement of obesity may result in the inaccurate classification of adiposity among patients.
- As an imaging marker, PFV may be the optimal tool for the assessment of body adiposity.
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A minimum of three contiguous voxels with a CT 
density of >130 Hounsfield units (HU) was considered 
to define the CAC area. Coronary artery stenosis 
severity was classified visually according to mean 
lumen diameter as normal, non-obstructed (reduction 
of <50%) or obstructive (reduction of ≥50% in a single 
vessel) by comparing the narrowest segment of the 
lumen diameter with the more proximal or distal 
normal segment in two orthogonal projections.9 
The part of the aorta lying within 3 cm of the caudal 
aspect of the aortic annulus containing the sinuses of 
Valsalva and the sinotubular junction was defined as 
the aortic root. According to this definition, total ARC 
was measured using the Agatston method [Figure 1].3 
Areas in the aortic root with an attenuation of >130 HU 
and an area of >1 mm2 were considered to be calcified 
lesions.3,10 Any adipose tissue located within the 
pericardial sac was considered to denote pericardial 
fat; this was measured three-dimensionally with a 
contrast-enhanced phase [Figure 2]. The pericardial 
layer was manually traced and a three-dimensional 
(3D) image of the heart constructed.9 The PFV was 
then estimated using a 3D workstation by measuring 
the total volume of pericardial tissue with a CT density 
between -250 and -20 HU. All MDCT data sets were 
evaluated by two independent radiologists with more 
than five years of experience in MDCT angiography 
data analysis.9 Significant differences between ARC, 
CAC and PFV markers among the BMI groups were 
analysed. Subsequently, the relationships between 
ARC, CAC and PFV in each group was analysed.
The presence of conventional cardiac risk factors 
for CAD was obtained from each patient at the time of 
the coronary MDCT angiography examination during 
clinical history-taking. Conventional cardiac risk 
factors included the following: positive family history 
of early CAD occurring before 55 years of age in men 
and 65 years of age in women; current smoking status 
and history defined as more than 10 cigarettes per 
day in the last year; history of hypertension or use of 
anti-hypertension medications; hyperlipidaemia (total 
cholesterol ≥200 mg/dL, triglyceride levels ≥150 mg/dL 
or use of lipid-lowering drugs); history of diabetes 
mellitus or use of antidiabetic or insulin-lowering 
drugs; and obesity (BMI of ≥30 kg/m2). Patients with 
two or more of these risk factors apart from obesity 
were considered to have multiple CAD risk factors.3,6
Data were analysed using the Statistical Package for 
the Social Sciences (SPSS), Version 13.0 (IBM Corp., 
Chicago, Illinois, USA). Results were presented as 
interquartile ranges (IQRs) or percentages, as appro- 
priate. Categorical data were expressed as frequencies 
and group comparisons were performed using 
Pearson’s Chi-squared test. Continuous variables 
were presented as median values and IQRs and 
were compared using the Student’s t-test, analysis of 
variance or non-parametric Mann-Whitney U test, as 
appropriate. Correlations between PFV, ARC and CAC 
were examined using Pearson’s correlation coefficient 
or Spearman’s rank correlation for nonparametric 
data. A multiple regression analysis was used to 
analyse correlations between the dependent variables 
(CAC, PFV and ARC) and the independent variable 
(BMI) after multivariate adjustment for age, gender, 
hypertension, smoking, diabetes, family history of 
premature CAD and hyperlipidaemia. A P value of 
<0.050 was considered statistically significant. 
This study was approved by the ethical committee 
of the Faculty of Medicine, University of Kufa. Inform-
ed consent was obtained from all patients included in 
the study.
Figure 2 A & B: Multi-detector computed tomography showing the measurement of pericardial fat volume (green shading) 
in the (A) axial and (B) coronal sections of the heart.
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Results 
Of the 111 patients included in the study, 54 were male 
(49%). The mean age of the total sample was 54.2 ± 
10.3 years. According to BMI category, 28 patients 
were obese (25%), 42 were overweight (38%) and 
41 were of normal weight (37%), with mean ages of 
51.3 ± 9.5 years, 56.8 ± 10.3 years and 54.7 ± 10.2 years, 
respectively. Median PFV (109 cm3; IQR: 52–176 cm3 
versus 97 cm3; IQR: 43–138 cm3) and ARC (0 Agatston 
score; IQR: 0–15 Agatston score versus 0 Agatston 
score; IQR: 0–0 Agatston score) values were highest in 
the normal weight group and lowest in the obese group, 
respectively. In comparison, median CAC values were 
highest in the obese group and lowest in the normal 
weight group (0 Agatston score; IQR: 0–54 Agatston 
score versus 0 Agatston score; IQR: 0–52 Agatston 
score). In the overweight group, the median PFV, 
ARC and CAC scores were 87 cm3 (IQR: 69–130 cm3), 
0 Agatston score (IQR: 0–2 Agatston score) and 
0 Agatston score (IQR: 0–53 Agatston score), 
respectively. Differences in PFV, CAC and ARC 
scores among the patient groups were not statistically 
significant (P = 0.419, 0.871 and 0.631, respectively). 
Additionally, there was no significant difference in the 
distribution of obstructive coronary stenosis among 
the groups (P = 0.121). The presence of CAD risk 
factors was also similar among the groups, except that 
there were more patients with multiple risk factors in 
the normal weight group compared to the obese and 
overweight groups (P = 0.032) [Table 1]. 
For the obese patients, no significant correlations 
were observed between PFV and CAC (r2 = 0.01; 
P = 0.167), obstructive coronary artery stenosis 
(r2 <0.01; P = 0.338) or ARC (r2 = 0.02; P = 0.266). Also, 
ARC showed no significant correlation with CAC 
(r2 = 0.04; P = 0.541) or obstructive coronary stenosis 
(r2 = 0.04; P = 0.335). In the overweight group, no 
significant correlation was observed between PFV 
and CAC (r2 = 0.03; P = 0.521), obstructive coronary 
stenosis (r2 <0.01; P = 0.611) or ARC (r2 = 0.01; 
P = 0.745); additionally, ARC showed no significant 
correlation with CAC (r2 = 0.03; P = 0.244) or 
obstructive coronary stenosis (r2 = 0.02; P = 0.322). In 
the normal weight group, a significant correlation was 
observed between PFV and CAC (r2 = 0.22; P = 0.002) 
and obstructive coronary stenosis (r2 = 0.18; P = 0.004), 
Table 1: Demographic and imaging characteristics and presence of risks factors among patients with suspected 
coronary artery disease (N = 111)





Normal weight group 
(n = 41)
Mean age ± SD 51.3 ± 9.5 56.8 ± 10.3 54.7 ± 10.2 0.217
Gender
Male 9(32) 23 (55) 22 (54) 0.156
Female 19 (68) 19 (45) 19 (46) 0.138
CAD risk factors
Hypertension 12 (43) 16 (38) 23 (56) 0.211
Smoking 6 (21) 10 (24) 13 (32) 0.510
Hyperlipidaemia 5 (18) 6 (14) 6 (15) 0.982
Diabetes 2 (7) 3 (7) 3 (7) 0.954
Family history of premature CAD 5 (18) 2 (5) 4 (10) 0.150
Multiple* 4 (14) 10 (24) 17 (41) 0.032
Imaging marker scores
Median CAC score (IQR) in Agatston 0 (0–54) 0 (0–53) 0 (0–52) 0.832
Median ARC score (IQR) in Agatston 0 (0–0) 0 (0–2) 0 (0–15) 0.632
Median PFV (IQR) in cm3 79 (43–138) 87 (69–130) 109 (52–176) 0.419
Obstructive coronary stenosis† 5 (18) 9 (21) 7 (17) 0.871
SD = standard deviation; CAD = coronary artery disease; CAC = coronary artery calcification; IQR = interquartile range; ARC = aortic root 
calcification; PFV = pericardial fat volume.
*Presence of two or more risk factors in the same patient. †Luminal stenosis ≥50%.
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although there was no significant correlation between 
PFV and ARC (r2 = 0.04; P = 0.113). The correlations 
between PFV and CAC (P = 0.003; confidence interval 
[CI] = 0.218–1.012) and between PFC and obstructive 
coronary stenosis (P = 0.03; CI = 6.441–137.517) 
persisted after multivariate adjustment for age, 
gender, ARC and conventional CAD risk factors. 
Furthermore, ARC showed a significant correlation 
with CAC (r2 = 0.37; P <0.001) and obstructive 
coronary stenosis (r2 = 0.23; P = 0.001); these correla- 
tions persisted after multivariate adjustment for age, 
gender, PFV and conventional CAD risk factors 
(P <0.001; CI = 0.342–0.870 and P = 0.003; 
CI = 6.742–29.445, respectively).
Multiple regression analysis was performed to 
assess the relationship of BMI with CAC, ARC and 
PFV in the sample after adjustment for age, gender 
and conventional CAD risk factors [Table 2]. No 
significant correlation was observed between BMI and 
any of these markers, including PFV [Figure 3].
Discussion
The use of BMI as a method for identifying obesity 
has several limitations. For example, BMI calculations 
do not usually take into consideration age, gender, 
bone structure, muscle mass or the time relationship 
between obesity and the clinical outcome being 
measured.7 Furthermore, BMI measurements do 
not differentiate between body weight due to muscle 
mass and weight due to adipose mass; the latter is 
now considered a key factor involved in various 
metabolic and cardiovascular disorders.1 Moreover, 
the relationship between BMI and percentage of 
adipose tissue is not linear and differs between men 
and women.7 In recent years, the results of several 
studies have suggested that obesity as determined by 
BMI is not necessarily equivalent to poor metabolic 
health or adverse cardiovascular outcomes; these 
findings have led to the generation of a new term—
metabolically healthy obesity—which refers to 
obese subjects who satisfy the current definition of 
obesity without being metabolically unhealthy.11–13 
Interestingly, ‘U’- or ‘J’-shaped associations between 
BMI and cardiovascular outcomes or mortality have 
been identified, in which obese patients show better 
outcomes in terms of cardiovascular morbidity and 
total mortality compared to patients of a normal 
weight.1,13 This inverse relationship between BMI and 
morbidity or mortality rates has been referred to as the 
“obesity paradox”.1,13 In a meta-analysis of data from 
89 studies including 1,300,794 patients, Wang et al. 
reported a ‘J’-shaped relationship between prognosis 
Table 2: Multiple regression analysis of imaging markers with body mass index and risk factors among patients with 
suspected coronary artery disease (N = 111)
CAD risk factor ARC PFV CAC
RC SE P value RC SE P value RC SE P value
BMI 0.59 0.9 0.521 0.04 0.6 0.993 1.63 0.9 0.933
HTN 18.82 27.1 0.434 2.21 16.7 0.863 152.21 113.3 0.112
Smoking 21.45 30.0 0.453 13.62 18.2 0.423 18.00 29.1 0.500
Diabetes 3.14 12.1 0.853 1.21 7.9 0.813 5.22 12.5 0.643
Hyperlipidaemia 21.54 33.4 0.514 11.13 20.6 0.552 9.10 32.6 0.752
Family history 11.62 43.5 0.723 12.53 26.8 0.612 7.42 42.1 0.825
Age 2.83 1.1 0.012 0.34 0.7 0.544 3.62 1.1 0.002
Male gender 53.31 25.6 0.031 15.72 15.8 0.311 22.43 25.4 0.362
CAD = coronary artery disease; ARC = aortic root calcification; PFV = pericardial fat volume; CAC = coronary artery calcification; RC = regression 
coefficient; SE = standard error; BMI = body mass index; HTN = hypertension.
Figure 3: Non-significant correlation between body 
mass index and pericardial fat volume among patients 
with suspected coronary artery disease (N = 111).
PFV = pericardial fat volume; BMI = body mass index.
Hussein Nafakhi, Abdulameer Al-Mosawi, Hayder Elwali, Hasan Al-Nafakh, Raad Tawfeq and Ahmed Nafakhi
Clinical and Basic Research | e315
and BMI in patients with CAD.14 Thus, the use of BMI 
as a measure of obesity may lead to bias in assessing 
relationships between obesity and cardiovascular 
health and outcomes.6
An inconsistent and complex relationship between 
obesity and vascular calcification has been described 
in the literature. Several studies have suggested 
that obesity is associated with increased CAC and 
calcification of the aorta; however, these studies 
were performed in relatively young populations or 
among individuals without known CAD or clinically 
significant coronary disease.15–18 On the other hand, 
an inverse relationship between vascular calcification 
and reduced bone density among the elderly has 
been suggested in more recent studies, whereby low 
BMI was independently associated with decreased 
bone mineral density which, in turn, was associated 
with increased vascular calcification.19,20 Rhee et al. 
compared CAC scores assessed by MDCT among 
24,000 participants with different metabolic health 
and obesity statuses; CAC levels were similar for both 
non-obese but metabolically unhealthy individuals 
and metabolically unhealthy obese paticipants.12 This 
finding suggests that metabolic health is more closely 
associated with CAC than obesity via a complex 
pathway.12 Recently, after studying the CT scans of 
276 participants scoring multiple arteries, including 
the coronary arteries and aorta, Takx et al. reported 
the systemic nature of cardiovascular calcifications, 
with a weak link between BMI and cardiovascular 
calcifications among different arterial beds.21
With regards to the relationship between PFV, 
vascular calcification and obesity, considerable evid- 
ence supports the vital role of pericardial fat 
accumulation in the coronary atherosclerosis process 
via the secretion of hormones and cytokines that 
modulate coronary artery haemostasis.6 The concept 
of normal weight obesity—defined as a normal BMI 
and excess body fat percentage—has been recently 
reported as an important risk factor for cardiovascular 
disease and metabolic dysregulation; higher amounts 
of visceral fat even with a normal BMI carry an 
elevated cardiovascular risk.22,23 Kim et al. reported 
that patients with normal weight obesity have a 
higher subclinical atherosclerosis incidence than 
normal weight lean patients due to a higher amount 
of visceral fat, regardless of other clinical risk factors 
for atherosclerosis.23 
A recent systematic review and meta-analysis of 
38 studies examining the relationship between 
epicardial fat and generalised obesity, central or visceral 
adipose tissue and the components of metabolic 
syndrome found a highly significant correlation 
between epicardial fat and BMI.24 Two CT-based 
studies found that increased cardiac fat was associated 
with CAD in non-obese patients and with metabolic 
syndrome regardless of BMI status.25,26 Additionally, 
a magnetic resonance imaging-based study reported 
that cardiac fat deposits were associated with a worse 
cardiometabolic profile in non-obese persons.27 
Nevertheless, it is important to note that there is 
significant heterogeneity between echocardiography-
based and CT-based studies in the assessment 
of cardiac fat deposits, whereby the volumetric 
quantification of cardiac fat using MDCT is highly 
reproducible compared to more simple measurements 
of thickness and area using echocardiography. Two-
dimensional echocardiographic measurements may 
not be accurate enough to assess the 3D-distribution 
of pericardial fat deposits.28 Moreover, the differences 
in anatomical description (pericardial versus epicardial 
fat) and discrepancies and ambiguities in the definition 
and nomenclature of fat deposits around the heart 
can attenuate the strength of reported associations 
between cardiac fat deposits and obesity.6 
 In the present study, significant correlations 
were observed between ARC and PFV with CAC in 
the normal weight group, while ARC, CAC and PFV 
showed no significant correlations in the overweight 
and obese groups. The assessment of different markers 
of coronary atherosclerosis through an automated 
(CAC and ARC) or semi-automated (PFV) scoring 
system using MDCT was a strength of the current 
study. However, there were several limitations. First, 
the patients were not randomly selected and only those 
patients with suspected CAD from a single centre 
were included, potentially resulting in selection bias 
which may limit generalisation of the results. Second, 
the sample size was relatively small. Third, causal 
relationships between PFV, ARC and CAC could not 
be inferred due to the cross-sectional design of the 
study. Fourth, the progression of CAC and ARC was 
not assessed; hence, obesity may have been associated 
with arterial calcification progression. Finally, a high 
BMI at the time of the MDCT examination may not 
necessarily reflect long-term obesity.
Conclusion
In the present study, PFV and ARC showed a significant 
correlation with subclinical coronary atherosclerosis 
(CAC and obstructive coronary stenosis) in normal 
weight patients. However, no significant correlations 
were observed for obese and overweight patients. 
These results suggest that BMI may not be an accurate 
tool for the measurement of adipose tissue or the 
assessment of arterial calcification burden among 
patients with suspected CAD.
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